Xeomin is set to be relaunched in the fight against wrinkles.
The botulinum toxin went off the market for ten months due to an injunction against the company that makes it, Merz.
Merz received the injunction notice based on claims that employees stole trade secrets from Allergen, the maker of Botox.
Read more: